This study tests an ointment called diacerein 1% for people with a rare genetic skin condition called generalized epidermolysis bullosa simplex (EBS), which causes fragile skin and painful blisters. About 80 participants aged 6 months and older will receive either the ointment or…
Phase: PHASE2, PHASE3 • Sponsor: TWi Biotechnology, Inc. • Aim: Disease control
Last updated May 18, 2026 12:00 UTC